Intraocular Lens Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Intraocular Lens Market Insights and it is segmented by Product (Mono focal Intraocular Lens, Accommodative Intraocular Lens, Multifocal Intraocular Lens, Toric Intraocular Lens), End User (Hospitals, Ambulatory Centers, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Values are Provided in Terms of USD Million for above segments.

Intraocular Lens Market Size

Single User License
Team License
Corporate License
Book before:
Intraocular Lens Market Summary
share button
Study Period 2019 - 2029
Market Size (2024) USD 6.46 Billion
Market Size (2029) USD 8.90 Billion
CAGR (2024 - 2029) 6.63 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Intraocular Lens Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License

Book before:

Intraocular Lens Market Analysis

The Intraocular Lens Market size is estimated at USD 6.46 billion in 2024, and is expected to reach USD 8.90 billion by 2029, growing at a CAGR of 6.63% during the forecast period (2024-2029).

The COVID-19 pandemic made patients hesitant to seek elective health care, including cataracts and other surgeries. The pandemic adversely affected the market and the resultant lockdowns placed by several countries. Visits to eye clinics or hospitals were reduced drastically, and only emergency procedures were performed. According to the data published by the National Center for Biotechnology Information in December 2021, patient numbers visiting eye care hospitals fell to a mere 3.5% in India. As the number of COVID-19 cases rose, many ophthalmologists temporarily closed their practices as a cautionary measure.

In some cases, specialized isolated temporary clinics were opened to manage critical cases among patients. During the pandemic, patients were more inclined toward telemedicine, which was critical in maintaining access to eye care. There was a very steep increase in the numbers in the secondary and tertiary centers from January 2021. Hence, the pandemic disrupted the market growth of intraocular lenses due to reduced ophthalmic practices and surgeries. However, the market is expected to witness significant growth in the future due to the increase in cataract surgery cases and the rise in the adoption of IOLs among the population.

Key factors propelling the intraocular lens market include increasing ophthalmic issues, growing cases of cataracts in the diabetic population, and rising adoption of advanced premium IOLs. According to the American Academy of Ophthalmology, in 2021, myopia, an eye-focusing disorder, was a significant, prevalent disease that affected an estimated 25% of Americans. Moreover, high myopia is associated with potentially blinding complications, such as glaucoma, retinal detachment, and myopic macular degeneration. Moreover, as per the International Myopia Institute, the researchers estimated that myopia and high myopia are expected to show a significant increase in prevalence globally, affecting nearly 5 billion people and 1 billion people, respectively, by 2050. Hence, such an increase in ophthalmic conditions across the world is expected to drive the growth of the IOL market over the forecast period.

Furthermore, an increase in diabetes is a significant driver of market expansion since diabetes causes various ophthalmic issues, including cataracts. As per the 2022 report from the International Diabetic Federation (IDF), 537 million people around the world will be living with diabetes in 2021, and the number is expected to rise to 643 million by 2030 and 783 million by 2045. Thus, as the diabetic population is more prone to suffer from cataracts, the market is likely to grow over the forecast period.

Moreover, many companies are launching new products and receiving approvals in the market to strengthen their position. For instance, in October 2021, Alcon Inc., a division of Novartis, launched the AcrySof IQ Vivity IOL (Vivity), the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology in India. Similarly, in November 2021, LensGen, Inc., a privately held ophthalmic medical device company, received approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal study of the company's Juvene intraocular lens (IOL), a premium lens for presbyopia. Additionally, in September 2022, Rayner publicized that the world's first implantations of RayOne EMV Toric had been performed by two highly respected surgeons from the UK. RayOne EMV Toric is the awaited toric variant of Rayner's popular RayOne EMV enhanced monofocal IOL that was developed in collaboration with Professor Graham Barrett. Thus, such product launches and strategic activities are expected to contribute to the market growth during the forecast period.

Owing to the increase in the number of ophthalmic issues and eye diseases rise in product launches and approvals, the demand for intraocular lenses is likely to rise throughout the forecast period. However, the increasing costs of IOLs and poor reimbursement coverage are expected to hamper the market growth over the forecast period.

Intraocular Lens Market Trends

Monofocal Intraocular Lens Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Monofocal intraocular (IOL) is an intraocular lens with a fixed focus from one distance. The intraocular lens focuses on the light that enters through the cornea and pupil onto the retina. A mono-focal intraocular lens has equal power in all regions and a single zone of clear focus, producing excellent vision from a determined distance. Patients with cataracts in both eyes prefer mono-focal intraocular lenses so they can select one of the three focuses for both eyes (near focus, mid-distance, and distant focus). A mono-focal intraocular lens is the first choice for many, as it can provide the best image quality after surgery.

Factors such as increasing research studies and product launches by key market players are expected to boost market growth over the forecast period. The study published in the Scientific Reports in January 2022 mentioned that cataracts and blepharoptosis are common ophthalmic problems in older adults in Korea; the prevalence of blepharoptosis in middle-aged to older adults is over 10%, and cataract is 15%. Also, as per the 2022 Vision Index report, research supported the prevalence of myopia, with most respondents (81%) having trouble seeing objects at a distance and short-sightedness being the most common diagnosis for those who have had their eyesight examined by an optometrist (40%) in Australia in 2022.

Thus, the increasing prevalence of ophthalmic disease boosts market growth over the forecast period. The rising product launches have increased the adoption of monofocal intraocular lenses. For instance, in March 2022, Alcon launched Clareon Monofocal, Clareon PanOptix, and Clareon Vivity IOLs in the US. Similarly, in February 2021, Johnson & Johnson received FDA approval for the next-generation mono-focal intraocular lens, Tecnis Eyhance, and Tecnis Eyhance Toric II IOLs, for the treatment of cataract patients. Furthermore, the advancements in technology and increasing product approvals, along with partnerships and collaborations by key players, are also anticipated to drive segment growth. For instance, in September 2022, SIFI SpA launched Evolux, a novel extended monofocal IOL based on a hydrophobic material and a non-diffractive profile, designed to provide better intermediate vision and equivalent distance vision when compared to a standard monofocal IOL. Similarly, in July 2022, cuFocus, Inc. received FDA approval for its breakthrough IC-8 Apthera intraocular lens (IOL) for the treatment of cataracts. The Apthera IOL is the first and only non-toric extended depth of focus IOL approved for 82% of cataract patients who have as much as 1.5 diopters (D) of corneal astigmatism.

Therefore, owing to the rising eye issues, increase in product launches, and the high demand for mono-focal intraocular lenses, the segment is predicted to grow over the forecast period.

Intraocular Lens Market : Estimated Research Funding for Eye Disease and Disorders of Vision (in USD Billion), United States, 2021-2023

North America is Expected to Witness Significant Growth in the Market Over the Forecast Period

North America is expected to hold a significant market share in the studied market over the forecast period, owing to an increase in vision-related disorders, high adoption of new technologies and products in the healthcare sector, and a surge in demand for better healthcare facilities. For instance, according to the ophthalmology management's May 2022 update, there are 128 million presbyopes living in the United States. That number grows every day as millennials are turning 40 and become presbyopic. Thus, an increase in cases of presbyopia is likely to drive the intraocular lens market over the forecast period.

Additionally, the increasing prevalence of cataract issues, such as age-related cataracts and congenital cataracts, is anticipated to propel the market's growth over the forecast period. According to statistics published by NVision Centers, in 2022, it was found that about 12 million people aged 40 years and above were suffering from vision impairment in the United States. Similarly, as per the May 2021 update by Fighting Blindness Canada, 1.2 million Canadians were living with vision loss in 2021. As per the same source, 8 million Canadians had an eye condition that could result in blindness. Hence, the market is anticipated to develop due to the rising frequency of eye illnesses and the increased need for intraocular lenses.

Product launches by market players in the region are another factor in market growth. For instance, in February 2021, Johnson and Johnson received approval from the FDA for the TECNIS Eyhance and TECNIS Eyhance Toric II intraocular lens for the treatment of cataract patients in the United States. Similarly, in January 2021, Alcon launched the AcrySof IQ Vivity IOL (Vivity), a non-diffractive extended depth of focus intraocular lens (IOL), in the United States. Vivity is a one-of-its-kind, non-diffractive extended depth of focus IOL which employs Alcon's proprietary non-diffractive X-WAVE technology, which stretches and shifts light without splitting the lens. Such product launches provide innovative and advanced products, which are expected to increase market growth during the forecast period.

Thus, the occurrence of high cases of vision-related disorders, the presence of major market players, and an increase in product launches in the country are expected to drive the growth of the studied market in North America.

Intraocular Lens Market  - Growth Rate by Region

Intraocular Lens Industry Overview

The intraocular lens market is moderately fragmented in nature. Major manufacturers of intraocular lenses are investing in mergers and acquisitions to expand revenue share and diversify product portfolios. Thus, the growing focus of companies in emerging countries and the gradual shift toward new technologies offer significant growth opportunities for players in the market. Some major market players include Alcon, Hoya Corporation, Carl Zeiss AG, Bausch Health Companies Inc., and EyeKon Medical Inc., among others.

Intraocular Lens Market Leaders

  1. HOYA Corporation

  2. Alcon Inc.

  3. EyeKon Medical Inc.

  4. Bausch Health Companies Inc.

  5. Carl Zeiss AG

*Disclaimer: Major Players sorted in no particular order

Intraocular Lens Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Intraocular Lens Market News

  • January 2023: Bausch + Lomb acquired AcuFocus, a privately held ophthalmic medical device company, gaining its novel small aperture non-toric extended depth of focus (EDOF) intraocular lens (IOL) available in Australia and New Zealand. AcuFocus is known for its small aperture intraocular technology, spearheaded by the IC-8 Apthera intraocular lens (IOL).
  • December 2022: Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, publicized the availability of TECNIS Synergy Toric II OptiBlue PC-IOL (intraocular lens) for patients with astigmatism in India.

Intraocular Lens Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Ophthalmic Issues and Eye Diseases in the Diabetic Population

      2. 4.2.2 Increasing Cases of Cataract in the Diabetic Population

      3. 4.2.3 Rising Adoption of Advanced Premium IOLs

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of IOLs

      2. 4.3.2 Lack of Reimbursement Policies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product

      1. 5.1.1 Monofocal Intraocular Lens

      2. 5.1.2 Accommodative Intraocular Lens

      3. 5.1.3 Multifocal Intraocular Lens

      4. 5.1.4 Toric Intraocular Lens

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Centers

      3. 5.2.3 Other End Users

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Alcon Inc.

      2. 6.1.2 Bausch Health Companies Inc.

      3. 6.1.3 Carl Zeiss Meditec AG

      4. 6.1.4 EyeKon Medical Inc.

      5. 6.1.5 Hoya Corporation

      6. 6.1.6 HumanOptics AG

      7. 6.1.7 Johnson and Johnson

      8. 6.1.8 Lenstec Inc.

      9. 6.1.9 Rayner Group

      10. 6.1.10 STAAR Surgical

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Intraocular Lens Industry Segmentation

As per the scope of the report, an intraocular lens is a lens implanted in the eye as part of a treatment for cataracts or myopia. Several types of intraocular lenses are available in the market to improve vision.

The Intraocular Lens market is segmented by Product (Monofocal Intraocular Lens, Accommodative Intraocular Lens, Multifocal Intraocular Lens, Toric Intraocular Lens), End User (Hospitals, Ambulatory Centers, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across the major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Monofocal Intraocular Lens
Accommodative Intraocular Lens
Multifocal Intraocular Lens
Toric Intraocular Lens
By End User
Ambulatory Centers
Other End Users
By Geography
North America
United States
United Kingdom
Rest of Europe
South korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Intraocular Lens Market Research FAQs

The Intraocular Lens Market size is expected to reach USD 6.46 billion in 2024 and grow at a CAGR of 6.63% to reach USD 8.90 billion by 2029.

In 2024, the Intraocular Lens Market size is expected to reach USD 6.46 billion.

HOYA Corporation, Alcon Inc., EyeKon Medical Inc., Bausch Health Companies Inc. and Carl Zeiss AG are the major companies operating in the Intraocular Lens Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Intraocular Lens Market.

In 2023, the Intraocular Lens Market size was estimated at USD 6.06 billion. The report covers the Intraocular Lens Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intraocular Lens Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Intraocular Lens Industry Report

Statistics for the 2024 Intraocular Lens market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Intraocular Lens analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Intraocular Lens Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)